Sculptor Capital LP Cassava Sciences Inc Call Options Transaction History

Sculptor Capital LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $1.21 Million - $2.7 Million	70,300 Added 1133.87%	76,500 $2.15 Million
Q1 2022 May 13, 2022	SELL	$32.6 - $53.05 $5.5 Million - $8.95 Million	-168,800 Reduced 96.46%	6,200 $230,000
Q4 2021 Feb 11, 2022	BUY	$36.77 - $90.91 $6.43 Million - $15.9 Million	175,000 New	175,000 $7.65 Million

206

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $121M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.